Development of the Pulmonary Surfactant System

The Lung: Development, Aging and The Environment

Volumn , Issue , 2003, Pages 149-167

  Orgeig, Sandra ^a   Daniels, Christopher B ^a   Sullivan, Lucy C ^a,b  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84942245730     PISSN: None     EISSN: None     Source Type: Journal    
DOI: 10.1016/B978-012324751-3/50044-9     Document Type: Article

References (253)

1. Goerke J. Pulmonary surfactant: functions and molecular composition. Biochim. Biophys. Acta 1998, 1408:79-89.
2. King RJ Isolation and chemical composition of pulmonary surfactant. Pulmonary Surfactant 1984, 1-15. Elsevier, Amsterdam. B. Robertson, L.M.G. van Golde, J.J. Batenburg (Eds.).
3. cockshutt AM, Possmayer F Metabolism of surfactant lipids and proteins in the developing lung. Pulmonary Surfactant: From Molecular Biology to Clinical Practice 1992, 339-377. Elsevier, Amsterdam. B. Robertson, L.M.G. van Golde, J.J. Batenburg (Eds.).
4. Batenburg JJ Surfactant phospholipids: synthesis and storage. Am. J. Physiol. 1992, 262:L367-L385.
5. Keough KMW Physical chemistry of pulmonary surfactant in the terminal airspaces. Pulmonary Surfactant: From Molecular Biology to Clinical Practice 1992, 109-164. Elsevier, Amsterdam. B. Robertson, L.M.G. van Golde, J.J. Batenburg (Eds.).
6. Possmayer F Physicochemical aspects of pulmonary surfactant. Fetal and Neonatal Physiology 1997, 1259-1275. W.B. Saunders Company, Philadelphia. R.A. Polin, W.W. Fox (Eds.).
7. Possmayer F Biophysical activities of pulmonary surfactant. Fetal and Neonatal Physiology 1991, 459-962. WB Saunders Co., Philadelphia. R.A. Polin, W.W. Fox (Eds.).
8. Pison U, Max M, Neuendank A, et al. Host defence capacities of pulmonary surfactant: evidence for 'non-surfactant' functions of the surfactant system. Eur. J. Clin. Invest. 1994, 24:586-599.
9. Meban C Effect of lipids and other substances on the adsorption of dipalmitoylphosphatidylcholine. Pediatr. Res. 1981, 15:1029-1031.
10. Qanbar R, Cheng S, Possmayer F, et al. Role of the palmitoylation of surfactant-associated protein C in surfactant film formation and stability. Am. J. Physiol. 1996, 271:L572-L580.
11. Veldhuizen RAW, Nag K, Orgeig S, et al. The role of lipids in pulmonary surfactant. Biochim. Biophys. Acta 1998, 1408:90-108.
12. Veldhuizen EJA, Haagsman HP Role of pulmonary surfactant components in surface film formation and dynamics. Biochim. Biophys. Acta 2000, 1467:255-270.
13. Orgeig S, Daniels CB The roles of cholesterol in pulmonary surfactant: insights from comparative and evolutionary studies. Comp. Biochem. Physiol. A 2001, 129:75-89.
14. Presti FT, Pace RJ, Chan SI Cholesterol phospholipid interaction in membranes. 2. Stoichiometry and molecular packing of cholesterol-rich domains. Biochemistry 1982, 21:3831-3835.
15. Oosterlaken Dijksterhuis MA, van Eijk M, van Buel BL, et al. Surfactant protein composition of lamellar bodies isolated from rat lung. Biochem. J. 1991, 274:115-119.
16. Wright JR, Wager RE, Hawgood S, et al. Surfactant apoprotein Mr=26 000-36 000 enhances uptake of liposomes by type II cells. J. Biol. Chem. 1987, 262:2888-2894.
17. Tenner AJ, Robinson SL, Borchelt J, et al. Human pulmonary surfactant protein (SP-A), a protein structurally homologous to Clq, can enhance FcR- and CR1-mediated phagocytosis. J. Biol. Chem. 1989, 264:13923-13928.
18. Korfhagen TR, Bruno MD, Ross GF, et al. Altered surfactant function and structure in SP-A gene targeted mice. Proc. Natl. Acad. Sci. USA 1996, 93:9594-9599.
19. Weaver TE Synthesis, processing and secretion of surfactant proteins B and C. Biochim. Biophys. Acta 1998, 1408:173-179.
20. Possmayer F, Yu S Role of the low molecular weight proteins in pulmonary surfactant. Progress in Respiratory Research. Basic Research on Lung Surfactant 1990, 54-63. Karger, Basel. P. von Wichert, B. Muller (Eds.).
21. Possmayer F The role of surfactant-associated proteins. Am. Rev. Respir. Dis. 1990, 142:749-752.
22. Weaver TE, Johnson Conkright J Functions of surfactant proteins B and C. Annu. Rev. Physiol. 2001, 63:555-578.
23. Johnasson J, Curstedt T Molecular structures and interactions of pulmonary surfactant components. Eur. J. Biochem. 1997, 244:675-693.
24. Crouch EC Structure, biologic properties, and expression of surfactant protein D (SP-D). Biochim. Biophys. Acta 1998, 1408:278-289.
25. Mason RJ, Voelker DR Regulatory mechanisms of surfactant secretion. Biochim. Biophys. Acta 1998, 1408:226-240.
26. Rubio S, Lacaze-Masmonteil T, Chailley-Heu B, et al. Pulmonary surfactant protein A (SP-A) is expressed by epithelial cells of small and large intestine. J. Biol. Chem. 1995, 270:12162-12169.
27. Bourbon JR, Chailley-Heu B Surfactant proteins in the digestive tract, mesentery, and other organs: evolutionary significance. Comp. Biochem. Physiol. A 2001, 129:151-161.
28. Paananen R, Glumoff V, Hallman M Surfactant protein A and D expression in the porcine Eustachian tube. FEBS Lett. 1999, 452:141-144.
29. Paananen R, Glumoff V, Sormunen R, et al. Expression and localization of lung surfactant protein B in Eustachian tube epithelium. Am. J. Physiol. 2001, 280:L214-L220.
30. Haagsman HP, Diemel RV Surfactant-associated proteins: functions and structural variation. Comp. Biochem. Physiol. A 2001, 129:91-108.
31. Daniels CB, Lopatko OV, Orgeig S Evolution of surface activity related functions of vertebrate pulmonary surfactant. Clin. Exp. Pharmacol. Physiol. 1998, 25:716-721.
32. Schürch S, Bachofen H, Goerke J, et al. Surface properties of rat pulmonary surfactant studied with the captive bubble method: adsorption, hysteresis, stability. Biochim. Biophys. Acta 1992, 1103:127-136.
33. Langman C, Orgeig S, Daniels CB Alterations in composition and function of surfactant associated with torpor in Sminthopsis crassicaudata. Am. J. Physiol. 1996, 271:R437-R445.
34. Baughman RP The uncertainties of bronchoalveolar lavage. Eur. Respir. J. 1997, 10:1940-1942.
35. Griese M Pulmonary surfactant in health and human lung diseases: state of the art. Eur. Respir. J. 1999, 13:1455-1476.
36. Veldhuizen RA, McCaig LA, Akino T, et al. Pulmonary surfactant subfractions in patients with the acute respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 1995, 152:1867-1871.
37. Raymondos K, Leuwer M, Haslam PL, et al. Compositional, structural, and functional alterations in pulmonary surfactant in surgical patients after the early onset of systemic inflammatory response syndrome or sepsis. Crit. Care Med. 1999, 27:82-89.
38. von Neergaard KV New notions on a fundamental principle of respiratory mechanics: the retractile force of the lung, dependent on the surface tension in the alveoli. Z. Ges. Exp. Med. 1929, 66:373-394.
39. Bastacky J, Lee CYC, Goerke J, et al. Alveolar lining layer is thin and continuous: low-temperature scanning electron microscopy of rat lung. J. Appl. Physiol. 1995, 79:1615-1628.
40. Schürch S Surface tension at low lung volumes: dependence on time and alveolar size. Respir. Physiol. 1982, 48:339-355.
41. Bachofen H, Hildebrandt J, Bachofen M Pressure-volume curves of air- and liquid-filled excised lungs-surface tension in situ. J. Appl. Physiol. 1970, 29:422-431.
42. Bachofen H, Schürch S, Urbinelli M, et al. Relations among alveolar surface tension, surface area, volume and recoil pressure. J. Appl. Physiol. 1987, 62:1878-1887.
43. Bachofen H, Schürch S Alveolar surface forces and lung architecture. Comp. Biochem. Physiol. 2001, 129:183-193.
44. Sanderson RJ, Paul GW, Vatter AE, et al. Morphological and physical basis for lung surfactant action. Respir. Physiol. 1976, 27:379-392.
45. Daniels CB, Orgeig S The comparative biology of pulmonary surfactant: past, present and future. Comp. Biochem. Physiol. A 2001, 129:9-36.
46. Crapo JD New concepts in the formation of pulmonary edema. Am. Rev. Respir. Dis. 1993, 147:790-792.
47. Gil J, Bachofen H, Gehr P, et al. Alveolar volume-surface area relation in air- and saline-filled lungs fixed by vascular perfusion. J. Appl. Physiol. 1979, 47:990-1001.
48. Guyton AC, Moffat DS, Adair TH Role of alveolar surface tension in transepithelial movement of fluid. Pulmonary Surfactant 1984, 171-185. Elsevier, Amsterdam. B. Robertson, L.M.G. Van Golde, J.J. Batenburg (Eds.).
49. Enhorning G Pulmonary surfactant function studied with the pulsating bubble surfactometer (PBS) and the capillary surfactometer (CS). Comp. Biochem. Physiol. 2001, 129:221-226.
50. Kilburn KH Alveolar clearance of particles: a bullfrog lung model. Arch. Environ. Health 1969, 18:556-563.
51. Kakuta Y, Sasaki H, Takishima T Effect of artificial surfactant on ciliary beat frequency in guinea pig trachea. Respir. Physiol. 1991, 83:313-322.
52. Allegra L, Bossi R, Braga P Influence of surfactant on mucociliary transport. Eur. J. Respir. Dis. 1985, 142:71-76.
53. Pikaar JC, Voorhout WF, Van Golde LMG, et al. Opsonic activities of surfactant proteins A and D in phagocytosis of gram-negative bacteria by alveolar macrophages. J. Infect. Dis. 1995, 172:481-489.
54. Ikegami M, Whitsett JA, Jobe A, et al. Surfactant metabolism in SP-D gene-targeted mice. Am. J. Physiol. 2000, 279:L468-L476.
55. Chander A, Fisher AB Regulation of lung surfactant secretion. Am. J. Physiol. 1990, 258:L241-L253.
56. Massaro D, Clerch L, Massaro GD Surfactant secretion: evidence that cholinergic stimulation of secretion is indirect. Am. J. Physiol. 1982, 243:C39-C45.
57. Rooney SA Regulation of surfactant secretion. Comp. Biochem. Physiol. A 2001, 129:233-243.
58. Brown LS, Longmore WJ Adrenergic and cholinergic regulation of lung surfactant secretion in the isolated perfused rat lung and in the alveolar type II cell in culture. J. Biol. Chem. 1981, 256:66-72.
59. Smith DM, Griffin LS Stereologic analysis of the in vivo alveolar type II cell response to isoproterenol or saline administration. Histol. Histopathol. 1987, 2:95-106.
60. Keeney SK, Oelberg DG Alpha-adrenergic and muscarinic receptors in adult and neonatal rat type II pneumocytes. Lung 1993, 171:355-366.
61. Dobbs LG, Mason RJ Pulmonary alveolar type II cells isolated from rats. J. Clin. Invest. 1979, 63:378-387.
62. Robinson PC, Voelker DR, Mason RJ Isolation and culture of human alveolar type II epithelial cells: characterization of their phospholipid secretion. Am. Rev. Respir. Dis. 1984, 130:1156-1160.
63. Smith DM, Smith SK Ultrastructural changes in the synthetic and secretory patterns of pulmonary surfactant following pilocarpine in vivo. Histol. Histopathol. 1997, 12:343-348.
64. Oyarzun MJ, Clements JA Ventilatory and cholinergic control of pulmonary surfactant in the rabbit. J. Appl. Physiol. 1977, 43:39-45.
65. Wood PG, Lopatko OV, Orgeig S, et al. Control of pulmonary surfactant secretion: an evolutionary perspective. Am. J. Physiol. 2000, 278:R611-R619.
66. Ormond CJ, Orgeig S, Daniels CB Neurochemical and thermal control of surfactant secretion by alveolar type II isolated from the marsupial Sminthopsis crassicaudata. J. Comp. Physiol. B 2001, 171:223-230.
67. Nicholas TE, Power JHT, Barr HA Surfactant homeostasis in the rat lung during swimming exercise. J. Appl. Physiol. 1982, 53:1521-1528.
68. Nicholas TE, Power JHT, Barr HA The pulmonary consequences of a deep breath. Respir. Physiol. 1982, 49:315-324.
69. Wirtz H, Schmidt M Ventilation and secretion of pulmonary surfactant. Clin. Invest. 1992, 70:3-13.
70. Wirtz HRW, Dobbs LG Calcium mobilization and exocytosis after one mechanical stretch of lung epithelial cells. Science 1990, 250:1266-1269.
71. Edwards YS, Sutherland LM, Power JH, et al. Cyclic stretch induces both apoptosis and secretion in rat alveolar type II cells. FEBS Lett. 1999, 448:127-130.
72. Veldhuizen RA, Tremblay LN, Govindarajam A, et al. Pulmonary surfactant is altered during mechanical ventilation of isolated rat lung. Crit. Care Med. 2000, 28:2545-2551.
73. Rice WR, Dorn CC, Singleton FM P2-purinoceptor regulation of surfactant phosphatidylcholine secretion: relative roles of calcium and protein kinase C. Biochem. J. 1990, 266:407-413.
74. Griese M, Gobran LI, Rooney SA A2 and P2 purine receptor interactions and surfactant secretion in primary cultures of type II cells. Am. J. Physiol. 1991, 261:L140-L147.
75. Gilfillan AM, Rooney SA Leukotrienes stimulate phosphatidylcholine secretion in cultured type II pneumocytes. Biochim. Biophys. Acta 1986, 876:22-27.
76. Sano K, Voelker DR, Mason RJ Effect of secretagogues on cytoplasmic-free calcium in alveolar type II epithelial cells. Am. J. Physiol. 1987, 253:C679-C686.
77. Sen N, Grunstein MM, Chander A Regulation of lung surfactant secretion by endothelin-1 rat alveolar type II cells. Am. J. Physiol. 1994, 266:L255-L262.
78. Brown LAS, Wood LH Stimulation of surfactant secretion by vasopressing in primary cultures of adult rat type II pneumocytes. Biochim. Biophys. Acta 1989, 1001:76-81.
79. Pian MS, Dobbs LG Lipoprotein-stimulated surfactant secretion in alveolar type II cells: mediation by heterotrimeric G proteins. Am. J. Physiol. 1997, 273:L634-L639.
80. Linke MJ, Burton FM, Fiedeldy DT, et al. Surfactant phospholipid secretion from rat alveolar type II cells: possible role of PKC isozymes. Am. J. Physiol. 1997, 272:L171-L177.
81. Dobbs LG, Wright JR, Hawgood S, et al. Pulmonary surfactant and its components inhibit secretion of phosphatidylcholine from cultured rat alveolar type II cells. Proc. Natl. Acad. Sci. USA 1987, 84:1010-1014.
82. Rice WR, Ross GF, Singleton FM, et al. Surfactant-associated protein inhibits phosphatidylcholine secretion from type II cells. J. Appl. Physiol. 1987, 63:692-698.
83. Suwabe A, Mason RJ, Voelker DR Temporal segregation of surfactant secretion and lamellar body biogenesis in primary cultures of rat alveolar type II cells. Am. J. Respir. Cell Mol. Biol. 1991, 5:80-86.
84. Benson BJ, Kitterman JA, Clements JA, et al. Changes in phospholipid composition of lung surfactant during development in the fetal lamb. Biochim. Biophys. Acta 1983, 753:83-88.
85. Katyal SL, Estes LW, Lombardi B Method for the isolation of surfactant from homogenates and lavages of adult, newborn and fetal rats. Lab. Invest. 1977, 36:585-592.
86. Torday JS, Nielson HC Surfactant phospholipid ontogeny in fetal rabbit lung lavage and amniotic fluid. Biol. Neonate 1981, 39:266-271.
87. Kulovich MV, Hallman MB, Gluck L The lung profile. I. Normal pregnancy. Am. J. Obstet. Gynecol. 1979, 135:57-63.
88. Mendelson CR, Boggaram V Hormonal control of the surfactant system in fetal lung. Annu. Rev. Physiol. 1991, 53:415-440.
89. Khoor A, Stahlman MT, Gray ME, et al. Temporal-spatial distribution of SP-B and SP-C proteins and mRNAs in developing respiratory epithelium of human lung. J. Histochem. Cytochem. 1994, 42(9):1187-1199.
90. Dulkerian SJ, Gonzales LW, Ning Y, et al. Regulation of surfactant protein D in human fetal lung. Am. J. Respir. Cell Mol. Biol. 1996, 15:781-786.
91. Ogasawara Y, Kuroki Y, Shiratoari M, et al. Ontogeny of surfactant apoprotein D, SP-D, in the rat lung. Biochim. Biophys. Acta 1991, 1083:252-256.
92. Schellenberg JC, Liggins GC, Manzi M, et al. Synergistic hormonal effects on lung maturation in fetal sheep. J. Appl. Physiol. 1988, 65:94-100.
93. Marino PA, Rooney SA Surfactant secretion in a newborn rabbit lung slice model. Biochim. Biophys. Acta 1980, 620:509-519.
94. Mendelson CR, Johnston JM, MacDonald PC, et al. Multihormonal regulation of surfactant synthesis by human fetal lung in vitro. J. Clin. Endocrinol. Metab. 1981, 53:307-317.
95. Hallman M, Wermer D, Epstein BL, et al. Effects of maternal insulin or glucose infusion on the fetus: study on lung surfactant phospholipids, plasma myoinositol, and fetal growth in the rabbit. Am. J. Obstet. Gynecol. 1982, 142:877-882.
96. Gross I, Wilson CM, Ingleson LD, et al. The influence of hormones on the biochemical development of fetal rat lung in organ culture. I. Estrogen. Biochim. Biophys. Acta 1979, 575:375-383.
97. Merrill JD, Ballard RA Antenatal hormone therapy for fetal lung maturation. Clin. Perinatol. 1998, 25:983-997.
98. Chelly N, Mouhieddine-Gueddiche O-B, Barlier-Mur A-M, et al. Keratinocyte growth factor enhances maturation of fetal rat lung type II cells. Am. J. Respir. Cell Mol. Biol. 1999, 20:423-432.
99. Yano T, Mason RJ, Pan T, et al. KGF regulates pulmonary epithelial proliferation and surfactant protein gene expression in adult rat lung. Am. J. Physiol. 2000, 279:L1146-L1158.
100. Challis JR, Brooks AN Maturation and activation of hypothalamic-pituitary adrenal function in fetal sheep. Endocrinol. Rev. 1989, 10:182-204.
101. Taylor RN, Lebovic DI, Martin-Cadieux MC The endocrinology of pregnancy. Basic and Clinical Endocrinology 2001, 575-602. Lange Medical Books/McGraw-Hill, New York. F.S. Greenspan, D.G. Gardner (Eds.).
102. Ballard PL, Ning Y, Polk D, et al. Glucocorticoid regulation of surfactant components in immature lambs. Am. J. Physiol. 1997, 273:L1048-L1057.
103. Ekelund L, Enhorning G Glucocorticoids and beta-adrenergic-receptor agonists: their combined effect on fetal rabbit lung surfactant. Am. J. Obstet. Gynecol. 1985, 152:1063-1067.
104. Ohashi T, Takada S, Motoike T, et al. Effect of dexamethasone on pulmonary surfactant metabolism in hyperoxia-treated rat lungs. Pediatr. Res. 1991, 29:173-177.
105. Platzker AC, Kitterman JA, Mescher EJ, et al. Surfactant in the lung and tracheal fluid of the fetal lamb and acceleration of its appearance by dexamethasone. Pediatrics 1975, 56:554-561.
106. Ballard PL, Hovey ML, Gonzales LK Thyroid hormone stimulation of phosphatidylcholine synthesis in cultured fetal rabbit lung. J. Clin. Invest. 1984, 74:898-905.
107. Gross I, Ballard PL, Ballard RA, et al. Corticosteroid stimulation of phosphatidylcholine synthesis in cultured fetal rabbit lung: evidence for de novo protein synthesis mediated by glucocorticoid receptors. Endocrinology 1983, 112:829-837.
108. Gonzales LW, Ballard PL, Ertsey R, et al. Glucocorticoids and thyroid hormones stimulate biochemical and morphological differentiation of human fetal lung in organ culture. J. Clin. Endocrinol. Metab. 1986, 62:678-691.
109. Sharma A, Gonzales LW, Ballard PL Hormonal regulation of cholinephosphate cytidylyltransferase in human fetal lung. Biochim. Biophys. Acta 1993, 1170:237-244.
110. Viscardi RM, Weinhold PA, Beals TM, et al. Cholinephosphate cytidylyltransferase in fetal rat lung cells: activity and subcellular distribution in response to dexamethasone, triiodothyronine, and fibroblast-conditioned medium. Exp. Lung Res. 1989, 15:223-237.
111. Smith BT Lung maturation in the fetal rat: acceleration by injection of fibroblast-pneumocyte factor. Science 1979, 204:1094-1095.
112. Post M, Barsoumian A, Smith BT The cellular mechanism of glucocorticoid acceleration of fetal lung maturation: fibroblast-pneumocyte factor stimulates cholinephosphate cytidylyltransferase activity. J. Biol. Chem. 1986, 261:2179-2184.
113. Suzuki R, Ichikawa F, Endo C, et al. A method of measuring dipalmitoylphosphatidylcholine (DPPC) by high-performance liquid chromatography (HPLC): effect of dexamethasone on DPPC secretion in fetal rat alveolar type II cell culture. J. Obstet. Gynaecol. Res. 1996, 22:481-488.
114. Tan RC, Ikegami M, Jobe AH, et al. Developmental and glucocorticoid regulation of surfactant protein mRNAs in preterm lambs. Am. J. Physiol. 1999, 277:L1142-L1148.
115. Guttentag SH, Beers MF, Bieler BM, et al. Surfactant protein B processing in human fetal lung. Am. J. Physiol. 1998, 275:L559-L566.
116. Solarin KO, Ballard PL, Guttentag SH, et al. Expression and glucocorticoid regulation of surfactant protein C in human fetal lung. Pediatr. Res. 1997, 42:356-364.
117. Wang JY, Yeh TF, Lin YC, et al. Measurement of pulmonary status and surfactant protein levels during dexamethasone treatment of neonatal respiratory distress syndrome. Thorax 1996, 51:907-913.
118. Ballard PL, Ertsey R, Gonzales LW, et al. Transcriptional regulation of human pulmonary surfactant proteins SP-B and SP-C by glucocorticoids. Am. J. Respir. Cell Mol. Biol. 1996, 14:599-607.
119. Whitsett JA, Pilot T, Clark JC, et al. Induction of surfactant protein in fetal lung: effects of cAMP and dexamethasone on SAP-35 RNA and synthesis. J. Biol. Chem. 1987, 262:5256-5261.
120. Liley HG, White RT, Ballard PL Glucocorticoids both stimulate and inhibit production of pulmonary surfactant protein A in fetal human lung. Proc. Natl. Acad. Sci. USA 1988, 85:9096-9100.
121. Kumar AR, Snyder JM Differential regulation of SP-A1 and SP-A2 genes by cAMP, glucocorticoids, and insulin. Am. J. Physiol. 1998, 274:L177-L185.
122. Prank L, Lewis PL, Sosenko IRS Dexamethasone stimulation of fetal rat lung antioxidant enzyme activity in parallel with surfactant stimulation. Pediatrics 1985, 75:569-573.
123. Walther FJ, David-Cu R, Metha EI, et al. Higher lung antioxidant enzyme activity persists after single dose of corticosteroids in preterm lambs. Am. J. Physiol. 1996, 271:L187-L191.
124. Ikegami M, Berry D, Elkady T, et al. Corticosteroids and surfactant change lung function and protein leaks in the lungs of ventilated premature rabbits. J. Clin. Invest. 1987, 79:1371-1378.
125. Wallace MJ, Hooper SB, Harding R Effects of elevated fetal cortisol concentrations on the volume, secretion, and reabsorption of lung liquid. Am. J. Physiol. 1995, 269:R881-R887.
126. Cheng JB, Goldfien A, Ballard PL, et al. Glucocorticoids increase pulmonary beta-adrenergic receptors in fetal rabbit. Endocrinology 1980, 107:1646-1648.
127. Maniscalco WM, Shapiro DL Effects of dexamethasone on beta-adrenergic receptors in fetal lung explants. Pediatr. Res. 1983, 17:274-277.
128. Isohama Y, Kumanda Y, Tanaka K, et al. Dexamethasone increases beta 2-adrenoceptor-regulated phosphatidylcholine secretion in rat alveolar type II cells. Jpn. J. Pharmacol. 1997, 73:163-169.
129. Isohama Y, Rooney SA Glucocorticoid enhances the response of type II cells from newborn rats to surfactant secretagogues. Biochim. Biophys. Acta 2001, 1531:241-250.
130. Jobe AH, Ikegami M Lung development and function in preterm infants in the surfactant treatment era. Annu. Rev. Physiol. 2000, 62:825-846.
131. Muglia L, Jacobson L, Dikkes P, et al. Corticotropin-releasing hormone deficiency reveals major fetal but not adult glucocorticoid need. Nature 1995, 373:427-432.
132. Post M, Smith BT Hormonal control of surfactant metabolism. Pulmonary Surfactant: From Molecular Biology to Clinical Practice 1992, 379-424. Elsevier, Amsterdam. B. Robertson, L.M.G. Van Golde, J.J. Batenburg (Eds.).
133. Cabello G, Levieux D Neonatal changes in the concentrations of thyrotropin, triiodothyronine, thyroxine and cortisol in the plasma of pre-term and full-term lambs. J. Dev. Physiol. 1980, 2:59-69.
134. Rooney SA, Marino PA, Gobran LI, et al. Thyrotropin-releasing hormone increases the amount of surfactant in developing fetal rat lung. Pediatr. Res. 1979, 13:623-625.
135. Liggins GC Thyrotrophin-releasing hormone (TRH) and lung maturation. Reprod. Fertil. Dev. 1995, 7:443-450.
136. Redding RA, Douglas WH, Stein M Thyroid hormone influence upon lung surfactant metabolism. Science 1972, 175:994-996.
137. Das DK, Ayromlooi J, Bandyopadhyay D, et al. Potentiation of surfactant release in fetal lung by thyroid hormone action. J. Appl. Physiol. 1984, 56:1621-1626.
138. Ramadurai SM, Nielsen HC, Chen Y, et al. Differential effects in vivo of thyroid hormone on the expression of surfactant phospholipid, surfactant protein mRNA and antioxidant enzyme mRNA in fetal rat lung. Exp. Lung Res. 1998, 24:641-657.
139. Smith BT, Sabry K Glucocorticoid-thyroid synergism in lung maturation: a mechanism involving epithelialmesenchymal interaction. Proc. Natl. Acad. Sci. USA 1983, 80:1951-1954.
140. Torday JS, Dow KE Synergistic effect of triiodothyronine and dexamethasone on male and female fetal rat lung surfactant synthesis. Dev. Pharmacol. Ther. 1984, 7:133-139.
141. Wilson M, Hitchcock KR, Douglas WH, et al. Hormones and the lung. II. Immunohistochemical localization of thyroid hormone binding in type II pulmonary epithelial cells clonally derived from adult rat lung. Anat. Rec. 1979, 195:611-619.
142. Gross I Regulation of fetal lung maturation. Am. J. Physiol. 1990, 259:L337-L344.
143. Das DK Hormonal control of pulmonary surfactant synthesis. Arch. Biochem. Biophys. 1983, 224:1-12.
144. Whitsett JA, Darovec-Beckerman C, Pollinger J, et al. Ontogeny of beta-adrenergic receptors in the rat lung: effects of hypothyroidism. Pediatr. Res. 1982, 16:381-387.
145. Liley HG, Hawgood S, Wellenstein GA, et al. Surfactant protein of molecular weight 28,000-36,000 in cultured human fetal lung: cellular localization and effect of dexamethasone. Mol. Endocrinol. 1987, 1:205-215.
146. Nichols KV, Floros J, Dynia DW, et al. Regulation of surfactant protein A mRNA by hormones and butyrate in cultured fetal lung. Am. J. Physiol. 1990, 259:L488-L495.
147. Rooney SA Lung surfactant. Environ. Health Perspect. 1984, 55:205-226.
148. Griese M, Gobran LI, Rooney SA Ontogeny of surfactant secretion in type II pneumocytes from fetal, newborn and adult rats. Am. J. Physiol. 1992, 262:L337-L343.
149. Ekelund L, Burgoyne R, Brymer D, et al. Pulmonary surfactant release in fetal rabbits as affected by terbutaline and aminophyllin. Scand. J. Clin. Lab. Invest. 1981, 41:237-245.
150. Kanjanapone V, Hartig-Beecken I, Epstein MF Effect of isoxsuprine on fetal lung surfactant in rabbits. Pediatr. Res. 1980, 14:278-281.
151. Padbury JF, Jacobs HC, Lam RW, et al. Adrenal epinephrine and the regulation of pulmonary surfactant release in neonatal rabbits. Exp. Lung Res. 1984, 7:177-186.
152. Mettler NR, Gray ME, Schuffman S, et al. Beta-adrenergic induced synthesis and secretion of phosphatidylcholine by isolated pulmonary alveolar type II cells. Lab. Invest. 1981, 45:575-586.
153. Bernhard W, Müller B, Von-Wichert P Beta-adrenergic priming of rats in vivo modulates the effect of beta-agonist in vitro on surfactant phospholipid metabolism of isolated lungs. Eur. J. Clin. Invest. 1994, 24:393-399.
154. Odom MJ, Snyder JM, Mendelson CR Adenosine 3',5'-monophosphate analogs and beta-adrenergic agonists induce the synthesis of the major surfactant apoprotein in human fetal lung in vitro. Endocrinology 1987, 121:1155-1163.
155. Padbury JF, Robertman B, Oddie TH, et al. Fetal catecholamines in response to labor and delivery. Obstet. Gynecol. 1982, 60:607-611.
156. Crittenden DJ, Alexander LA, Beckman DL Sympathetic nerve influence on alveolar type II cell ultrastructure. Life Sci. 1994, 55:1229-1235.
157. Warburton D, Parton L, Buckley S, et al. Beta-receptors and surface active material flux in fetal lamb lung: female advantage. J. Appl. Physiol. 1987, 63:828-833.
158. Pysher TJ, Konrad KD, Reed GB Effects of hydrocortisone and pilocarpine on fetal rat lung explants. Lab. Invest. 1977, 37:588-594.
159. Delahunty TJ, Johnston JM Neurohumoral control of pulmonary surfactant secretion. Lung 1979, 157:45-51.
160. Lawson EE, Birdwell RL, Huang PS, et al. Augementation of pulmonary surfactant secretion by lung expansion at birth. Pediatr. Res. 1979, 73:611-614.
161. Oulton M, Fraser M, Dolphin M, et al. Quantification of surfactant pool sizes in rabbit lung during perinatal development. J. Lipid Res. 1986, 27:602-612.
162. Gluck L, Sribney M, Kulovich MV The biochemical development of surface activity in mammalian lung. II. The biosynthesis of phospholipids in the lung of the developing rabbit fetus and neuborn. Pediatr. Res. 1967, 1:247-265.
163. Rooney SA, Wai-Lee TS, Gobran L, et al. Phospholipid content, composition and biosynthesis during fetal lung development in the rabbit. Biochim. Biophys. Acta 1976, 413:447-458.
164. Torday JS, Sanchez-Esteban J, Rubin LP Paracrine mediators of mechanotransduction in lung development. Am. J. Med. Sci. 1998, 316:205-208.
165. Torday JS, Sun H, Qin J Prostaglandin E2 integrates the effects of fluid distension and glucocorticoid on lung matutation. Am. J. Physiol. 1998, 274:L106-L111.
166. Blewett CJ, Zgleszewski SE, Chinoy MR, et al. Bronchial ligation enhances fetal lung development in whole-organ culture. J. Pediatr. Surg. 1996, 31:869-877.
167. Flecknoe S, Harding R, Maritz G, et al. Increased lung expansion alters the proportions of type I and type II alveolar epithelial cells in fetal sheep. Am. J. Physiol. 2000, 278:L1180-L1185.
168. Islam S, Donahoe PK, Schnitzer JJ Tracheal ligation increases mitogen-activated protein kinase activity and attenuates surfactant protein B mRNA in fetal sheep lungs. J. Surg. Res. 1999, 84:19-23.
169. Lines A, Nardo L, Phillips ID, et al. Alterations in lung expansion affect surfactant protein A, B, and C mRNA levels in fetal sheep. Am. J. Physiol. 1999, 276:L239-L245.
170. Lines A., Gillett AM, Phillips ID, et al. Re-expression of pulmonary surfactant proteins following tracheal obstruction in fetal sheep. Exp. Physiol. 2001, 86:55-63.
171. Nakamura T, Liu M, Mourgeon E, et al. Mechanical strain and dexamethasone selectively increase surfactant protein C and tropoelastin gene expression. Am. J. Physiol. 2000, 278:L974-L980.
172. Hallman M, Glumoff V, Ramet M Surfactant in respiratory distress syndrome and lung injury. Comp. Biochem. Physiol. A 2001, 129:287-294.
173. Floros J, Wang G A point of view: quantitative and qualitative inbalance in disease pathogenesis; pulmonary surfactant protein A genetic variants as a model. Comp. Biochem. Physiol. A 2001, 129:295-303.
174. Cole FS, Hamvas A, Nogee LM Genetic disorders of neonatal respiratory function. Pediatr. Res. 2001, 50:157-162.
175. Nogee LM, deMello DE, Dehner LP, et al. Deficiency of pulmonary surfactant protein B in cogenital alveolar proteinosis. N. Engl. J. Med. 1993, 328:406-410.
176. Nogee LM, Garnier G, Dietz HC, et al. A mutation in the respiratory disease in multiple kindreds. J. Clin. Invest. 1994, 93:1860-1863.
177. Hamvas A, Nogee LM, deMello DE, et al. Pathophysiology and treatment of surfactant protein-B deficiency. Biol. Neonate 1995, 67:18-31.
178. Beers MF, Hamvas A, Moxley MA, et al. Pulmonary surfactant metabolism in infants lacking surfactant protein B. Am. J. Respir. Cell Mol. Biol. 2000, 22:380-391.
179. Hamvas A, Nogee LM, Mallory GB, et al. Lung transplantation for treatment of infants with surfactant protein B deficiency. J. Pediatr. 1997, 130:231-239.
180. Hamvas A, Cole F, deMello DE, et al. Surfactant protein B deficiency: antenatal diagnosis and prospective treatment with surfactant replacement. J. Pediastr. 1994, 125:356-361.
181. Tokieda K, Whitsett JA, Clark JC, et al. Pulmonary dysfunction in neonatal SP-B-deficient mice. Am. J. Physiol. 1997, 273:L875-L882.
182. Stahlman MT, Gray MP, Falconieri MW, et al. Lamellar body formation in normal and surfactant protein B-deficient fetal mice. Lab. Invest. 2000, 80:395-403.
183. Vorbroker DK, Profitt SA, Nogee LM, et al. Aberrant processing of surfactant protein C in hereditary SP-B deficiency. Am. J. Physiol. 1995, 268:L647-L656.
184. Voorhout WF, Weaver TE, Haagsman HP, et al. Biosynthetic routing of pulmonary surfactant proteins in alveolar type II cells. Microsc. Res. Tech. 1993, 26:366-373.
185. Beal SM Sudden infant death syndrome: epidemiological comparisons between South Australia and communities with a different incidence. Aust. Paediatr. J. 1986, (Suppl. 1):13-16.
186. Kylstra JA, Schoenfish WH Alveolar surface tension in fluorocarbon-filled lungs. J. Appl. Physiol. 1972, 33:32-35.
187. Curley AE, Halliday HL The present status of exogenous surfactant for the newborn. Early Hum. Dev. 2001, 61:67-83.
188. Ballard PL, Nogee LM, Beers MF, et al. Partial deficiency of surfactant protein B in an infant with chronic lung disease. Pediatrics 1995, 96:1046-1052.
189. Klein JM, Thompson MW, Snyder JM, et al. Transient surfactant protein B deficiency in a term infant with severe respiratory failure. J. Pediatr. 1998, 132:244-248.
190. Dunbar AE, Wert SE, Ikegami M, et al. Prolonged survival in hereditary surfactant protein B (SP-B) deficiency associated with a novel splicing mutation. Pediatr. Res. 2000, 48:275-282.
191. Nogee LM, Wert SE, Proffit SA, et al. Allelic hetetegeneity in hereditary surfactant protein B (SP-B) deficiency. Am. J. Respir. Crit. Care Med. 2000, 161:973-981.
192. Amin RS, Wert SE, Baughman RP, et al. Surfactant protein deficiency in familial interstitial lung disease. J. Pediatr. 2001, 139:85-92.
193. Tryka AF, Wert SE, Mazursky JE, et al. Absence of lamellar bodies with accumulation of dense bodies characterizes a novel form of congenital surfactant defect. Pediatr. Dev. Pathol. 2000, 3:335-345.
194. Cutz E, Wert SE, Nogee LM, et al. Deficiency of lamellar bodies in alveolar type II cells associated with fatal respiratory disease in a full-term infant. Am. J. Respir. Crit. Care Med. 2000, 161:608-614.
195. Minior VK, Divon MY Fetal growth restriction at term: myth or reality?. Obstet. Gynecol. 1998, 92:57-60.
196. Tyson JE, Kennedy K, Broyles S, et al. The small for gestational age infant: accelerated or delayed pulmonary muturation? Increased or decreased survival?. Pediatrics 1995, 95:534-538.
197. Creasy RK, Resnik R Intrauterine growth restriction. Maternal-Fetal Medicine 1994, 558-574. Sauders, Philadelphia PA. R.K. Creasy, R. Resnik (Eds.).
198. Gagnon R, Challis J, Johnston L, et al. Fetal endocrine responses to chronic placental embolization in the lategestation ovine fetus. Am. J. Obstet. Gynecol. 1994, 170:929-938.
199. Nicolaides KH, Economides DL, Soothill PW Blood gases, pH, and lactate in appropriate-and small-for-gestational-age fetuses. Am. J. Obstet. Gynecol. 1989, 161:996-1001.
200. Owens JA, Kind KL, Carbone F, et al. Circulating insulin-like growth factors-I and-II and substrates in fetal sheep following restriction of placental growth. J. Endocrinol. 1994, 140:5-13.
201. Gross I, Ballard PL Hormonal therapy for prevention of respiratory distress syndrome. Fetal and Neonatal Physiology 1997, 1314-1321. Saunders, Philadelphia, PA. R.A. Polin, W.W. Fox (Eds.).
202. Jobe AH Pathophysiology of respiratory distress syndrome and surfactant metabolism. Fetal and Neonatal Physiology 1997, 1299-1313. Saunders, Philadelphia, PA. R.A. Polin, W.W. Fox (Eds.).
203. Gross TL, Sokol RJ, Wilson MV, et al. Amniotic fluid phosphatidylglycerol: a potentially useful predictor of intrauterine growth retardation. Am. J. Obstet. Gynecol. 1981, 140:277-281.
204. Rees S, Ng J, Dickson K, et al. Growth retardation and the development of the respiratory system in fetal sheep. Early Hum. Dev. 1991, 26:13-27.
205. Lechner AJ, Winston DC, Bauman JE Lung mechanics cellularity, and surfactant after prenatal starvation in guinea pigs. J. Appl. Physiol. 1986, 60:1610-1614.
206. Lin Y, Lechner AJ Surfactant content and type II cell development in fetal guinea pig lungs during prenatal starvation. Pediatr. Res. 1991, 29:288-291.
207. Braems GA, Han VK, Challis JR Gestational age-dependent changes in the levels of mRNAs encoding cortisol biosynthetic enzymes and IGF-II in the adrenal gland of fetal sheep during prolonged hypoxemia. J. Endocrinol. 1998, 159:257-264.
208. Braems GA, Yao LJ, Inchley K, et al. Ovine surfactant protein cDNAs: use in studies on fetal lung growth and maturation after prolonged hypoxemia. Am. J. Physiol. 2000, 278:L754-L764.
209. Gagnon R, Langridge J, Inchley K, et al. Changes in surfactant-associated protein mRNA profile in growth-restricted fetal sheep. Am. J. Physiol. 1999, 276:L459-L465.
210. Cock ML, Albuquerque CA, Joyce BJ, et al. Effects of intrauterine growth restriction on lung liquid dynamics and lung development in fetal sheep. Am. J. Obstet. Gynecol. 2001, 184:209-216.
211. Nardo L, Hooper SB, Harding R Lung hypoplasia can be reversed by short-term obstruction of the trachea in fetal sheep. Pediatr. Res. 1995, 38:690-696.
212. Borok Z, Danto SI, Lubman RL, et al. Modulation of tlalpha expression with alveolar epithelial cell phenotype in vitro. Am. J. Physiol. 1998, 275:L155-L164.
213. Lines A, Nardo L, Phillips ID, et al. Alterations in lung expansion affect surfactant protein A, B, and C mRNA levels in fetal sheep. Am. J. Physiol. 1999, 276:L239-L245.
214. Sanchez-Esteban J, Tsai SW, Sang J, et al. Effects of mechanical forces on lung-specific gene expression. Am. J. Med. Sci. 1998, 316:200-204.
215. Avery ME, Mead J Surface properties in relation to atelectasis and hyaline membrane disease. Am. Med. Assoc. J. Dis. Child. 1959, 97:517-523.
216. Clements JA, Hustead RF, Johnson RP, et al. Pulmonary surface tension and alveolar stability. J. Appl. Physiol. 1961, 16(3):444-450.
217. Pattle RE, Claireaux AE, Davies PA, et al. Inability to form a lung-lining as a cause of the respiratory-distress syndrome in the newborn. Lancet 1962, 2:469-473.
218. Mauskopf JA, Backhouse ME, Jones D, et al. Synthetic surfactant for rescue treatment of respiratory distress syndrome in premature infants weighing from 700 to 1350 grams: impact on hospital resource use and charge. J. Pediatr. 1995, 126:94-101.
219. Bancalari E, del Moral T Bronchopulmonary dysplasia and surfactant. Biol. Neonate 2001, 80:7-13.
220. Stevens PA, Schadow B, Bartholain S, et al. Surfactant protein A in the course of respiratory distress syndrome. Eur. J. Pediatr. 1992, 151:596-600.
221. Taieb J, Francoual J, Magny JF, et al. Surfactant-associated protein A determination using a chemiluminescence system-application to tracheal aspirates from newborns. Clin. Chim. Acta 1995, 235:229-234.
222. Shelley SA, Kovacevic M, Paciga JE, et al. Sequential changes of surfactant phosphatidylcholine in hyaline-membrane disease of the newborn. N. Engl. J. Med. 1979, 300:112-116.
223. Motoyama EK, Namba Y, Rooney SA Phosphatidylcholine content and fatty acid composition of tracheal and gastric liquids from premature and full-term newborn infants. Clin. Chim. Acta 1976, 70:449-454.
224. Ashton MR, Postle AD, Hall MA, et al. Phosphatidylcholine composition of endotracheal tube aspirates of neonates and subsequent respiratory disease. Arch. Dis. Child. 1992, 67:278-382.
225. Hallman M, Merritt TA, Pohjavuori M, et al. Effect of surfactant substitution on lung effluent phospholipids in respiratory distress syndrome: evaluation of surfactant phospholipid turnover, pool size, and the relationship to severity of respiratory failure. Pediatr. Res. 1986, 20:1228-1235.
226. Griese M, Dietrich P, Reinhardt D Pharmacokinetics of bovine surfactant in neonatal respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 1995, 152:1050-1054.
227. Morley CJ, Hill CM, Brown BD, et al. Surfactant abnormalities in babies dying from sudden infant death syndrome. Lancet 1982, 1:1320-1323.
228. Ikegami M, Jacobs H, Jobe A Surfactant function in respiratory distress syndrome. J. Pediatr. 1983, 102:443-447.
229. Griese M, Westerburg B Surfactant function in neonates with respiratory distress syndrome. Respiration 1998, 65:136-142.
230. Hallman M, Merritt TA, Kari A, et al. Factors affecting surfactant responsiveness. Ann. Med. 1991, 23:693-698.
231. Kari MA, Raivio KO, Venge P, et al. Dexamethasone treatment of infants at risk for chronic lung disease: surfactant components and inflammatory parameters in airway specimens. Pediatr. Res. 1994, 36:387-393.
232. Nortway WH, Rosan RC, Porter DY Pulmonary disease following respiratory therapy of hyaline-membrane disease: bronchopulmonary dysplasia. N. Engl. J. Med. 1967, 276:357-368.
233. Avery ME, Tooley WH, Keller JB, et al. Is chronic lung disease in low birth weight infants preventable? A survey of eight centers. Pediatrics 1987, 79:26-30.
234. Stahlman MT, Gray ME, Hull WM, et al. Immunolocalization of surfactant protein-D (SP-D) in human fetal, newborn, and adult tissues. J. Histochem. Cytochem. 2002, 50:651-660.
235. D'Angio CT, Finkelstein JN, Lomonaco MB, et al. Changes in surfactant protein gene expression in a neonatal rabbit model of hyperoxia-induced fibrosis. Am. J. Physiol. 1997, 272:L720-L730.
236. Minoo P, Segura L, Coalson JJ, et al. Alterations in surfactant protein gene expression associated with premature birth and exposure to hyperoxia. Am. J. Physiol. 1991, 261:L386-L392.
237. Awasthi S, Coalson JJ, Crouch E, et al. Surfactant proteins A and D in premature baboons with chronic lung injury (bronchopulmonary dysplasia): evidence for an inhibition of secretion. Am. J. Respir. Crit. Care Med. 1999, 160:942-949.
238. Awasthi S, Coalson JJ, Yoder BA, et al. Deficiencies in lung surfactant proteins A and D are associated with lung infection in very premature neonatal babooms. Am. J. Respir. Crit. Care Med. 2001, 163:389-397.
239. Kazzi SN, Schürch S, McLaughlin KL, et al. Surfactant phospholipids and surface activity among preterm infants with respiratory distress syndrome who develop broncho-pulmonary dysplasia. Acta Paediatr. 2000, 89:1218-1225.
240. Coalson JJ, Winter VT, Gerstmann DR, et al. Pathophysiologic, morphometric, and biochemical studies of the premature baboon with bronchopulmonary dysplasia. Am. Rev. Respir. Dis. 1992, 145:872-881.
241. Tapia JL, Ramirez R, Cifuentes J, et al. The effect of early dexamethasone administration on bronchopulmonary dysplasia in preterm infants with respiratory distress syndrome. J. Pediatr. 1998, 132:48-52.
242. Rudiger M, von Baehr A, Haupt R, et al. Preterm infants with high polyunsaturated fatty acid and plasmalogen content in tracheal aspirates develop bronchopulmonary dysplasia less often. Crit. Care Med. 2000, 28:1572-1577.
243. Everard ML Bronchiolitis: origins and optimal management. Drugs 1995, 49:885-896.
244. Löfgren J, Ramet M, Renko M, et al. Association between surfactant protein A gene locus and severe respiratory syncytial virus infection in infants. J. Infect. Dis. 2002, 185:283-289.
245. American Academy of Pediatrics Committee on Infectious Diseases Use of ribavirin in the treatment of respiratory syncytial virus infection. Pediatrics 1993, 92:501-504.
246. Anderson LJ, Parker RA, Strikas RL Association between respiratory syncytial virus outbreaks and lower respiratory tract deaths of infants and young children. J. Infect. Dis. 1990, 161:640-646.
247. LeVine AM, Lotze A, Stanley S, et al. Surfactant content in children with inflammatory lung disease. Crit. Care Med. 1996, 24:1062-1067.
248. Dargaville PA, South M, McDougall PN Surfactant abnormalities in infants with severe viral bronchiolitis. Arch. Dis. Child. 1996, 75:133-136.
249. Tibby SM, Hatherill M, Wright SM, et al. Exogenous surfactant supplementation in infants with respiratory syncytial virus bronchiolitis. Am. J. Respir. Crit. Care Med. 2000, 162:1251-1256.
250. Skelton R, Holland P, Darowski M, et al. Abnormal surfactant composition and activity in severe bronchiolitis. Acta Paediatr. 1999, 88:942-946.
251. Rämet M, Haataja R, Marttila R, et al. Association between the surfactant protein A (SP-A) gene locus and respiratory-distress syndrome in the Finnish population. Am. J. Hum. Genet. 2000, 66:1569-1579.
252. Kala P, Ten Have T, Nielsen H, et al. Association of pulmonary surfactant protein A (SP-A) gene and respiratory distress syndrome: interaction with SP-B. Pediatr. Res. 1998, 43:169-177.
253. Rakshi K, Couriel JM Management of acute bronchiolitis. Arch. Dis. Child. 1994, 71:463-469.